The Finnish Formula: Finding Balance and Building Innovation with Dr. Antti Vuolanto
In this episode of Clinical Trialblazers, Dr. Antti Vuolanto, CEO of Herantis Pharma Plc, shares his unconventional journey into the biotech industry, from bioengineering to leading a company focused on central nervous system (CNS) diseases. He discusses the scientific innovation behind HER096, a potential game-changer for Parkinson's disease, and the challenges of drug development. Beyond the science, Dr. Vuolanto offers profound lessons on the importance of building trust with colleagues and investors, the importance of taking risks, and the importance of work-life balance (a Finnish secret to happiness!). This episode highlights the power of mentorship, honest communication, and a deep commitment to impacting patients’ lives. He discusses the importance of mentorship, the challenges of drug development, and the significance of building trust with investors.
Related Insights
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
CTB Podcast
Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
May 12, 2025
CTB Podcast
From Mentee to CEO, Board Member and Mentor
Apr 17, 2025
CTB Podcast
Leading through setbacks with Cytokinetics
Mar 26, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
CTB Podcast
Introducing Clinical Trialblazers!
Mar 6, 2025
Related Insights
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
CTB Podcast
Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
May 12, 2025
CTB Podcast
From Mentee to CEO, Board Member and Mentor
Apr 17, 2025
CTB Podcast
Leading through setbacks with Cytokinetics
Mar 26, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
CTB Podcast
Introducing Clinical Trialblazers!
Mar 6, 2025